MEDP (MEDP)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$15.73B
EV / Sales5.65
EV / EBITDA26.11
EV / Operating Cash Flow20.89
EV / Free Cash Flow21.44

Return Metrics (TTM)

Return on Equity (ROE)110.15%
Return on Assets (ROA)23.89%
Return on Invested Capital (ROIC)77.00%
Return on Capital Employed (ROCE)93.83%

Yield Metrics

Earnings Yield3.01%
Free Cash Flow Yield4.55%

Balance Sheet Strength

Net Debt / EBITDA-0.64
Current Ratio0.73
Working Capital-$385.14M
Tangible Asset Value-$261.64M
Net Current Asset Value-$573.03M

Working Capital Efficiency

Days Sales Outstanding57.96
Days Payables Outstanding6.91
Operating Cycle (Days)57.96
Cash Conversion Cycle51.05

Capital Allocation

CapEx / Revenue0.69%
CapEx / Operating Cash Flow2.54%
R&D / Revenue0.00%
SG&A / Revenue6.79%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin30.06%
Operating Margin21.14%
Net Profit Margin17.83%

Solvency

Debt / Equity0.55
Quick Ratio0.74
Cash Ratio0.37

Per Share

Revenue / Share$87.72
FCF / Share$23.64
PE Ratio35.91